Skip to main content
Explore URMC
menu

Evaluation of Chemotherapy (Carboplatin) Dosing with Contrast Agent, Iohexol

Research Question:
How well does iohexol, a contrast agent, work in helping doctors calculate the dose of carboplatin given to patients with cancer?

Basic Study Information

Purpose:
This trial studies how well iohexol, a contrast agent, works in helping doctors calculate the dose of carboplatin given to patients with cancer. A contrast agent is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Understanding how to best calculate the dose of carboplatin given to patients with cancer may help doctors learn how to improve the use of carboplatin in the future.

Location: University of Rochester Medical Center
Study Reference #: CMLT20003

Lead Researcher (Principal Investigator)

Lead Researcher:  Richard Moore

Study Contact Information

Study Coordinator: Barbara Kavinsky
Phone: (585) 273-3602
Email: Barbara_Kavinsky@URMC.Rochester.edu

Additional Study Details

Return to Search